Domenico Barone
Meldola, Italy
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 33 publications
Toward a PSMA PET-mpMRI pathway for biopsy decision-making in men with suspected prostate cancer: interim results from the prospective BIOPSTAGE trial.
Journal: Frontiers in oncology
Published: October 08, 2025
Radiopsy: a prospective observational study on quantitative multiparametric whole-body magnetic resonance imaging to discriminate between smoldering and multiple myeloma.
Journal: Haematologica
Published: February 19, 2025
Changing metastatic patterns associate with dynamics of circulating tumor DNA in metastatic castration-resistant prostate cancer.
Journal: The oncologist
Published: June 19, 2023
Patient centered radiology: investigating 3 Tesla whole body MRI acceptance in cancer patients.
Journal: La Radiologia medica
Published: March 14, 2023
Prognostic and Predictive Role of Body Composition in Metastatic Neuroendocrine Tumor Patients Treated with Everolimus: A Real-World Data Analysis.
Journal: Cancers
Published: April 28, 2022
Inflammatory Biomarkers for Outcome Prediction in Patients With Metastatic Testicular Cancer.
Journal: Frontiers in oncology
Published: March 31, 2022
Radiomics Analysis on [68Ga]Ga-PSMA-11 PET and MRI-ADC for the Prediction of Prostate Cancer ISUP Grades: Preliminary Results of the BIOPSTAGE Trial.
Journal: Cancers
Published: February 08, 2022
3-T magnetic resonance-guided high-intensity focused ultrasound (3 T-MR-HIFU) for the treatment of pain from bone metastases of solid tumors.
Journal: Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer
Published: December 09, 2021
Plasma tumor DNA is associated with increased risk of venous thromboembolism in metastatic castration-resistant cancer patients.
Journal: International journal of cancer
Published: May 19, 2021
Computed tomography based analyses of body mass composition in HER2 positive metastatic breast cancer patients undergoing first line treatment with pertuzumab and trastuzumab.
Journal: Scientific reports
Published: April 26, 2021
The Primacy of High B-Value 3T-DWI Radiomics in the Prediction of Clinically Significant Prostate Cancer.
Journal: Diagnostics (Basel, Switzerland)
Published: March 05, 2021
Last Updated: 09/26/2026